
Bayer Aktiengesellschaft (BAYN.DE)
- Previous close
47.00 - Open
46.50 - Bid 46.90 x 28400
- Ask 46.94 x 2100
- Day's range
46.10 - 47.60 - 52-week range
24.81 - 49.78 - Volume
4,365,030 - Avg. Volume
2,869,233 - Market cap (intra-day)
46.086B - Beta (5Y monthly) 0.85
- PE ratio (TTM)
-- - EPS (TTM)
-2.19 - Earnings date (est.) 4 Aug 2026
- Forward dividend & yield 0.11 (0.23%)
- Ex-dividend date 27 Apr 2026
- 1y target est
50.58
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
www.bayer.com87,757
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Drug Manufacturers - General
Industry
Recent news
View morePerformance overview
Trailing total returns as of 26/06/2026, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD return
1-year return
3-year return
5-year return
Earnings trends
View moreAnalyst insights
View moreStatistics
View moreValuation measures
Market cap
46.17B
Enterprise value
74.77B
Trailing P/E
--
Forward P/E
10.78
PEG ratio (5-yr expected)
--
Price/sales (ttm)
1.02
Price/book (mrq)
1.60
Enterprise value/revenue
1.65
Enterprise value/EBITDA
23.65
Financial highlights
Profitability and income statement
Profit margin
-4.76%
Return on assets (ttm)
3.64%
Return on equity (ttm)
-6.93%
Revenue (ttm)
45.24B
Net income avi to common (ttm)
-2.16B
Diluted EPS (ttm)
-2.19
Balance sheet and cash flow
Total cash (mrq)
6.66B
Total debt/equity (mrq)
134.27%
Levered free cash flow (ttm)
7.31B
Compare
Select to analyse similar companies using key performance metrics; select up to four stocks.





